This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Ocular Drug Therapies / Oral Delivery of Macromolecules
October 26-27, 2022 | 2-Day Digital Conference
Digital Conference8:00AM EST // 1:00PM BST // 2:00PM CEST

Vipul Yadav
Chief Executive Officer at Intract Pharma Ltd, UK
Speaker

Profile

Vipul’s research expertise encompasses small molecule and biological drug development, with particular knowledge of overcoming the biological barriers in the gastrointestinal tract to achieve oral administration of biopharmaceuticals. He received his Master of Science degree in Drug Delivery at The School of Pharmacy, University of London, where he researched oral peptide delivery. He then pursued a Ph.D. in Pharmaceutics at the UCL School of Pharmacy, where his research was aimed at exploring the biological mechanisms involved in the oral delivery and intestinal uptake of anti-TNF-α monoclonal antibodies.

Agenda Sessions

  • Oral Colon Targeted Delivery of Antibodies for Local Treatment of IBD

    12:35